AYVAKIT® Approved for Treatment of Indolent Systemic MastocytosisThe Mast Cell Disease Society is very excited to share the news of the FDA approval of AYVAKIT®(avapritinib).This is the first and only FDA approved treatment for Indolent Systemic Mastocytosis!To learn more, check out Blueprint Medicine’s press release and patient community letter!